Threonine175, a novel pathological phosphorylation site on tau protein linked to multiple tauopathies

Table 1 Case demographics

Neuropathological diagnosis	Age	n (n Male)
AD	72 ± 8	3 (2)
VD	78 ± 11	2 (1)
ALS	56 ± 16	5 (4)
ALSci	64 ± 11	6 (5)
DLBD	68 ± 1	2 (2)
mDLDB	83 ± 6	3 (3)
FTLD	64 ± 9	4 (1)
MSA	69 ± 12	6 (3)
PD	77 ± 2	5 (4)
Pick’s	70 ± 2	2 (2)
CBD	71 ± 1	2 (1)
Control 1	55 ± 2	6 (4)
Control 2	64 ± 2	6 (4)
Control 3	75 ± 3	8 (4)

AD Alzheimer’s disease, VD Vascular dementia, ALS amyotrophic lateral sclerosis, ALSci ALS with cognitive impairment, DLBD diffuse Lewy body dementia, mDLBD Lewy body dementia with mixed pathology, FTLD frontotemporal lobar dementia, MSA multiple system atrophy, PD Parkinson’s disease, Pick’s Pick’s disease, CBD corticobasal degeneration. Control 1: 6^th decade control group, Control 2: 7^th decade control group, Control 3: 8^th decade control group

ISSN: 2051-5960